Skip to content

E4 Pharmaceutical Consulting

E4 Biotechnology and Pharmaceutical Consulting. Providing product development (CMC), regulatory, QA/QC and project management support to companies developing new small-molecule drugs, biologics and medical devices.

cropped-E4-Logo-512×512.png

http://e4consult.com/wp-content/uploads/2017/09/cropped-E4-Logo-512×512.png

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Δ

Post navigation

Published in cropped-E4-Logo-512×512.png

Search for:

Categories

Regulatory (2)
- Regulatory Strategy (1)
- Regulatory Submissions (2)

E4 Pharmaceutical Consulting

Log in
Entries feed
Comments feed
WordPress.org

FDA News

Pharma Times

Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis
New cell therapy shows potential in treating advanced blood disorder
CatalYm shows potential of visugromab for treating cachexia
New findings presented at international SCWD conference
Imfinzi receives NICE recommendation for lung cancer treatment
Trial results lead to new treatment option for lung cancer
Poolbeg Pharma presents positive results for POLB 001
promising pre-clinical data on preventing cytokine release syndrome
Teva’s Ajovy shows positive results in preventing pediatric migraines
Phase 3 trial indicates significant efficacy and safety for children and adolescents
NICE endorses Neuraxpharm’s ublituximab for treating MS
New antibody therapy shows promise in managing condition

Proudly powered by WordPress / Theme: Shoreditch by Automattic.